ESICM News

Hyponatraemia: Diagnosis & Treatment

Hyponatraemia: Diagnosis & Treatment

Clinical guidelines published in ICM journal

The long anticipated guidelines to help diagnose and treat Hyponatraemia, a condition that occurs in up to 30% of hospitalised patients were published Feb. 25 in the journal Intensive Care Medicine. The guidelines recommend that every hospital-based clinician must be able to correctly diagnose, classify and treat hyponatraemia, which is associated with morbidity, mortality and longer length of hospital stay in a wide range of conditions.

Hyponatraemia is a complicated disorder of water balance, with a relative excess of body water compared to sodium and potassium (defined as a serum sodium concentration <135mmol/l). It has a wide variety of underlying causes, and may result in swelling (known as cellular oedema). Cells of the brain are particularly vulnerable to damage by swelling, making severe cases medical emergencies. Milder cases can be associated with impaired mobility and cognition, as well as osteoporosis and fracture in chronic conditions.

The guideline development group, comprising representatives from the European Society of Intensive Care Medicine (ESICM), the European Society of Endocrinology (ESE) and the European Renal Association – European Dialysis and Transplant Association (ERA–EDTA), conducted a literature review to collate the best available evidence on the diagnosis and management of hypotonic hyponatraemia.

The guidelines describe a pathway for diagnosis, which is less reliant on specialist laboratory resources, and can be conducted in the general hospital setting, in particular during ‘out-of-office hours’.

"These guidelines are essential in helping the diagnosis and treatment of hyponatraemia, which is a frequent condition which you can see in both the emergency room and the intensive care unit”. ~Michael Joannidis, contributing author of the clinical guidelines

The treatment pathway described in the document focuses more closely on the patients’ symptoms, giving lower priority to biochemical diagnosis. The guidelines recommend that as the risks to the patient’s brain are so great, in severe cases action is more important than investigation until the patient is stabilised.

Recent studies have shown that this is a condition that is associated with significant morbidity and enhanced mortality." Explains Michael Joannidis, a contributing author of the guidelines."These guidelines are essential in helping the diagnosis and treatment of hyponatraemia, which is a frequent condition which you can see in both the emergency room and the intensive care unit”.

The clinical practice guidelines on the diagnosis and treatment of hyponatraemia is published  in the March issue of Intensive Care Medicine (2014) and is open access: Clinical practice guideline on diagnosis and treatment of hyponatraemia

<Back to the news list
Comment on this news Comment on this news
To respond to this article, thank you for identifying
ReactionsReactions (0)